title: Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
authors.forename: Chor Sang
authors.initials: CS
authors.lastname: Chim
authors.forename: Pak Tat
authors.initials: PT
authors.lastname: Choi
authors.forename: Wai Ki
authors.initials: WK
authors.lastname: Lee
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D020031:Epstein-Barr Virus Infections / Q000473:pathology / Q000821:virology; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000473:pathology / Q000821:virology; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000601:surgery; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000473:pathology / Q000821:virology; D011719:Pyrazines / Q000008:administration & dosage; D016879:Salvage Therapy; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D019172:Transplantation Conditioning / Q000009:adverse effects; D014182:Transplantation, Autologous; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D001761:Bleomycin; D013792:Thalidomide; D014750:Vincristine; D014747:Vinblastine; D000069286:Bortezomib; D003606:Dacarbazine; D003907:Dexamethasone; D004317:Doxorubicin; D000077269:Lenalidomide